World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

Obesity as a global public health issue is a relatively recent but growing problem for all countries. Obesity arises from a set of complex interactions in individuals including genetics, neurobiology, and eating behaviors, as well as obesogenic environments resulting from shifts in diet, activity, and lifestyle alongside globalization and industrialization of food production and marketing.